Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
First Genesis is a private technology company that provides AI and data infrastructure rather than developing therapeutic products. Its core offering, Xenese, is positioned as a real-time, explainable, and cryptographically anchored decision infrastructure platform that supports edge, cloud, and hybrid environments. The company markets Xenese across multiple verticals including healthcare and life sciences, where it emphasizes connecting fragmented systems, data, and workflows to improve operational and clinical decision support. Based on available public information, First Genesis appears to be a health-adjacent enterprise software company rather than a biotech, pharma, or drug-development company, and no proprietary therapeutic pipeline was identified.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on First Genesis.